[1]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息,2018,(03):21-24.[doi:10.3969/j.issn.1006-1959.2018.03.007]
 RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Medical Information,2018,(03):21-24.[doi:10.3969/j.issn.1006-1959.2018.03.007]
点击复制

基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2018年03期
页码:
21-24
栏目:
肿瘤专题
出版日期:
2018-02-01

文章信息/Info

Title:
The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer
文章编号:
1006-1959(2018)03-0021-04
作者:
芮昆昆1章 波2邰小华2冯联忠2
1.蚌埠医学院,安徽 蚌埠 233000;2.嘉兴市第二医院肿瘤外科,浙江 嘉兴 314000
Author(s):
RUI Kun-kun1ZHANG Bo2TAI Xiao-hua2FENG Lian-zhong2
The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer
关键词:
MMP-2CIP2A胃癌
Keywords:
MMP-2CIP2AGastric cancer
分类号:
R735.2;R73-3
DOI:
10.3969/j.issn.1006-1959.2018.03.007
文献标志码:
A
摘要:
基质金属蛋白酶是机体内发挥重要作用的一类蛋白水解酶,作为该家族中的重要成员之一,在肿瘤细胞的侵袭转移过程中起重要作用,并受HER-2、Vav3、E-Cad/β-catenin 通路等多种蛋白分子,基因及信号通路的调节。蛋白磷酸酶2A的癌性抑制因子是近几年发现的一种主要在肿瘤组织中表达的癌性抑制因子,在胃癌细胞的增殖、转化及抗衰老等过程中发挥重要作用。
Abstract:
Matrix metalloproteinases are a class of proteolytic enzymes in the body which play an important role,as one of the important members of the class,MMP-2 plays an important role in tumor cell invasion and metastasis process,and regulated by HER-2,Vav3,E-Cad/β-catenin pathway protein molecules,gene and signal pathways of cancer.Inhibitor of protein phosphatase 2A is a recently discovered inhibitor that mainly expressed in tumor tissue,it plays an important role in the proliferation,transformation and anti-aging of gastric cancer cells.

参考文献/References:

[1]Lee SH,Kim IH,Kim IH,et al.Comparison of short-term outcomes and acute inflammatory response between laparoscopyassisted and totally laparoscopic distal gastrectomy for earlygastric cancer[J].Ann Surg Treat Res,2015,89(4):176-182.
[2]Bck M,Ketelhuth D F J,Agewall S.Matrix Metalloproteinases in Atherothrombosis[J].Progress in Cardiovascular Diseases,2010,52(5):410-428.
[3]Nagase T,Kikuno R,Ohara O.Prediction of thecoding sequences of unidentified human genes.XXII.The complete sequences of 50 new DNA clones which code for large proteins[J].DNA Res,2001,8:319-327.
[4]Junttila M R,Puustinen P,Niemel M,et al.CIP2A Inhibits PP2A in Human Malignancies[J].Cell,2007,130(1):51-62.
[5]Gialeli C,Theocharis AD,Karamanos NK.Roles of matrix metalloproteinases in Cancer progression and their pharmacological targeting[J].FEBS J,2011,278(1):16-27.
[6]Hadler-Olsen E,Winberg JO,Uhlin-Hansen L.Matrix metalloproteinases in cancer:their value as diagnostic and prognostic markers and therapeutic targets[J].Tumor Biol,2013,34(4):2041-2051.
[7]Mumby M.PP2A:unveiling a reluctant tumor suppressor[J].Cell,2007,130(1):21-24.
[8]Ji J,Zhen W,Si Y,et al.Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer[J].Cancer Biomarkers,2017:1-10.
[9]Pathak A,Kumar S.Independent regulation oftumor cell migration by matrix stiffness andconfinement[J].Proc Natl AcadSci USA,2012(109):10334-10339.
[10]杨云鹏,刘莉,李慧.MMP-2,MMP-3 和 MMP-9 在胃癌患者中的表达及意义[J].局解手术学杂志,2016,25(9):625-628.
[11]刘蕾,彭佳,黄金玲,等.化痰通瘀解毒方水提取物对胃癌 SGC-7901 细胞划痕愈合及 E-cadherin 和 MMP-2 表达的影响[J].云南中医学院学报,2016,39(6):1-4.
[12]Wang Y,Wu H,Wu X,et al.Interleukin 17A promotes gastric cancer invasiveness via NF-κB mediated matrix metalloproteinases 2 and 9 expression[J].PloS one,2014,9(6):e96678.
[13]陈鹤林,朱小琪.幽门螺杆菌感染胃癌组织 MMP-2,TIMP-2 表达及其对胃癌侵袭和转移的影响[J].中国病原生物学杂志,2013,8(9):793-795.
[14]Ji L,Zhang B,Zhao G.Liver X receptor α(LXRα)promoted invasion and EMT of gastric cancer cells by regulation of NF-κB activity[J].Human Cell,2017,30(2):124-132.
[15]He Q,Chen J.Expression of peroxisome proliferator-activated receptor gamma,E-cadherin andmatrixmetalloproteinases-ingastric carcinoma and lymph node metastases[J].Chin Med J (Engl),2007,120(17):1498-1504.
[16]刘艳萍,李国庆,陈宏辉,等.卡培他滨治疗晚期胃癌的疗效及对患者血清MMP-2、MMP-9水平的影响[J].世界华人消化杂志,2015(7):1136-1140.
[17]Foley C J,Fanjulfernández M,Bohm A,et al.Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis[J].Oncogene,2013,33(17):2264-2272.
[18]廖世平,高青.血管生成拟态及相关蛋白Mig-7、MMP-2在胃癌组织中的表达及临床意义[J].细胞与分子免疫学杂志,2013,29(2):194-196.
[19]王钧,赵玉亭,宋展.HER-2与MMP-2在胃癌中的表达和意义[J].中国现代医生,2013,51(28):147-148.
[20]陈俊强,詹文华,何裕隆,等.胃癌淋巴结转移预测的 Logistic 回归分析[J].中华胃肠外科杂志,2005,8(5):436-439.
[21]王一波,汤黎明.MMP-2、MMP-7和MMP-14在胃癌患者组织中表达的临床意义[J].实用临床医药杂志,2015,19(15):44-48.
[22]裴惠临.胃癌组织Twist与MMP-2的表达及临床病理意义[J].武汉大学学报(医学版),2017,38(1):31-35.
[23]Li W,Ge Z,Liu C,et al.CIP2A is overexpressed in gastric cancer andits depletion leads to impaired clonogenicity,senescence,or differentiation of tumor cells[J].ClinCancer Res,2008, 14:3722-3728.
[24]Khanna A,Bckelman C,Hemmes A,et al.MYC-dependent regulation and prognostic role of CIP2A in gastric cancer[J].Jnci Journal of the National Cancer Institute,2009,101(11):793-805.
[25]Li W,Ge Z,Liu C,et al.CIP2A Is Overexpressed in Gastric Cancer and Its Depletion Leads to Impaired Clonogenicity, Senescence,or Differentiation of Tumor Cells[J].Clinical Cancer Research An Official Journal of the American Association for Cancer Research,2008,14(12):3722.
[26]师海蓉.CIP2A shRNA真核表达载体的构建及其对胃癌细胞增殖的抑制作用[J].基础医学与临床,2015,35(2):162-166.
[27]师海蓉.靶向CIP2A的shRNA对人胃癌BGC-823细胞增殖、凋亡及侵袭的影响[J].华中科技大学学报(医学版),2014, 43(5):528-531.
[28]Zhao Y,Li Y,Han J,et al.Helicobacter pylori enhances CIP2A expression and cell proliferation via JNK2 ATF2 signaling in human gastric cancer cells[J].International journal of molecular medicine,2014,33(3):703-710.
[29]Liu C Y,Hu M H,Chia-Jung H,et al.Lapatinib inhibits CIP2A PP2A p-Akt signaling and induces apoptosis in triple negative breast cancer cells[J].Oncotarget,2016,7(8):9135-9149.
[30]Zhao D,Liu Z,Ding J,et al.Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK ERK pathways[J].Journal of medical microbiology,2010,59(3):259-265.
[31]Lekstan A,Lampe P,Lewin-Kowalik J,et al.Concentrationsand activities of metalloproteinases 2 and 9 and their inhibitors(TIMPS)in chronic pancreatitis and pancreatic adenocarcinoma[J].J PhysiolPharmacol,2012,63(6):589.
[32]Khanna A,Pimanda J E.Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers[J].International journal of cancer,2016,138(3):525-532.
[33]Barragán E,Chillón MC,Castelló-Cros R,et al.CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia[J].Haematologica.2015,100(5):e183-185.

更新日期/Last Update: 2018-02-01